KZA 0.00% 8.0¢ kazia therapeutics limited

The 2022 ambiguous announcement was a straight up hit piece by...

  1. PT3
    315 Posts.
    lightbulb Created with Sketch. 177
    The 2022 ambiguous announcement was a straight up hit piece by the executive board individuals of the Agile trial that have a resume to include biopharma acquisition experts and Big Pharma ties. For those with discernment you would know it was a hit piece and should have expected such an attack with Garner showing Kazia’s underbelly with the ATM and Paxalisib being a drug clinician around the world are asking to have access to.

    If you bought the dips and didn’t drink the poison of misinformation spread by Big Pharma and the media you are going to do very well!!!






 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.